دورية أكاديمية

Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review.

التفاصيل البيبلوغرافية
العنوان: Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review.
المؤلفون: Pandey, Ambarish, Garg, Sushil, Matulevicius, Susan A, Shah, Amil M, Garg, Jalaj, Drazner, Mark H, Amin, Alpesh, Berry, Jarett D, Marwick, Thomas H, Marso, Steven P, de Lemos, James A, Kumbhani, Dharam J
المصدر: Department of Medicine
بيانات النشر: LVHN Scholarly Works
سنة النشر: 2015
المجموعة: Lehigh Valley Health Network: LVHN Scholarly Works
مصطلحات موضوعية: Chi-Square Distribution, Diastole, Fibrosis, Heart Failure, Humans, Mineralocorticoid Receptor Antagonists, Randomized Controlled Trials as Topic, Recovery of Function, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Ventricular Function, Ventricular Remodeling, Department of Medicine, Fellows and Residents, Medicine and Health Sciences
الوصف: BACKGROUND: There has been an increasing interest in use of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure with preserved ejection fraction (HFPEF). However, a comprehensive evaluation of MRA effects on left ventricular (LV) structure and function in these patients is lacking. In this meta-analysis, we evaluated the effects of MRAs on LV structure and function among patients with diastolic dysfunction or HFPEF. METHODS & RESULTS: Randomized, controlled clinical trials evaluating the efficacy of MRAs in patients with diastolic dysfunction or HFPEF were included. The primary outcome was change in E/e', a specific measure of diastolic function. Secondary outcomes included changes in other measures of diastolic function, LV structure, surrogate markers for myocardial fibrosis (carboxy-terminal peptide of procollagen type I [PICP] and amino-terminal peptide of pro-collagen type-II [PIIINP]), blood pressure, and exercise tolerance. In the pooled analysis, MRA use was associated with significant reduction in E/e' (weighted mean difference [WMD] [95% confidence interval {CI}]: -1.68 [-2.03 to -1.33]; P CONCLUSION: MRA therapy in patients with asymptomatic diastolic dysfunction or HFPEF is associated with significant improvement in diastolic function and markers of cardiac fibrosis without a significant change in LV mass or dimensions.
نوع الوثيقة: text
اللغة: unknown
العلاقة: https://scholarlyworks.lvhn.org/medicine/5058Test; https://pubmed.ncbi.nlm.nih.gov/26459931Test/
الإتاحة: https://scholarlyworks.lvhn.org/medicine/5058Test
https://pubmed.ncbi.nlm.nih.gov/26459931Test/
رقم الانضمام: edsbas.5372F5C2
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.5372F5C2
792
3
Academic Journal
academicJournal
792.1474609375
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.5372F5C2&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://scholarlyworks.lvhn.org/medicine/5058# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review. )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Pandey%2C+Ambarish%22">Pandey, Ambarish</searchLink><br /><searchLink fieldCode="AR" term="%22Garg%2C+Sushil%22">Garg, Sushil</searchLink><br /><searchLink fieldCode="AR" term="%22Matulevicius%2C+Susan+A%22">Matulevicius, Susan A</searchLink><br /><searchLink fieldCode="AR" term="%22Shah%2C+Amil+M%22">Shah, Amil M</searchLink><br /><searchLink fieldCode="AR" term="%22Garg%2C+Jalaj%22">Garg, Jalaj</searchLink><br /><searchLink fieldCode="AR" term="%22Drazner%2C+Mark+H%22">Drazner, Mark H</searchLink><br /><searchLink fieldCode="AR" term="%22Amin%2C+Alpesh%22">Amin, Alpesh</searchLink><br /><searchLink fieldCode="AR" term="%22Berry%2C+Jarett+D%22">Berry, Jarett D</searchLink><br /><searchLink fieldCode="AR" term="%22Marwick%2C+Thomas+H%22">Marwick, Thomas H</searchLink><br /><searchLink fieldCode="AR" term="%22Marso%2C+Steven+P%22">Marso, Steven P</searchLink><br /><searchLink fieldCode="AR" term="%22de+Lemos%2C+James+A%22">de Lemos, James A</searchLink><br /><searchLink fieldCode="AR" term="%22Kumbhani%2C+Dharam+J%22">Kumbhani, Dharam J</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Department of Medicine )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => LVHN Scholarly Works )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2015 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Lehigh Valley Health Network: LVHN Scholarly Works )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Chi-Square+Distribution%22">Chi-Square Distribution</searchLink><br /><searchLink fieldCode="DE" term="%22Diastole%22">Diastole</searchLink><br /><searchLink fieldCode="DE" term="%22Fibrosis%22">Fibrosis</searchLink><br /><searchLink fieldCode="DE" term="%22Heart+Failure%22">Heart Failure</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Mineralocorticoid+Receptor+Antagonists%22">Mineralocorticoid Receptor Antagonists</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+Controlled+Trials+as+Topic%22">Randomized Controlled Trials as Topic</searchLink><br /><searchLink fieldCode="DE" term="%22Recovery+of+Function%22">Recovery of Function</searchLink><br /><searchLink fieldCode="DE" term="%22Stroke+Volume%22">Stroke Volume</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+Outcome%22">Treatment Outcome</searchLink><br /><searchLink fieldCode="DE" term="%22Ventricular+Dysfunction%22">Ventricular Dysfunction</searchLink><br /><searchLink fieldCode="DE" term="%22Left%22">Left</searchLink><br /><searchLink fieldCode="DE" term="%22Ventricular+Function%22">Ventricular Function</searchLink><br /><searchLink fieldCode="DE" term="%22Ventricular+Remodeling%22">Ventricular Remodeling</searchLink><br /><searchLink fieldCode="DE" term="%22Department+of+Medicine%22">Department of Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Fellows+and+Residents%22">Fellows and Residents</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine+and+Health+Sciences%22">Medicine and Health Sciences</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => BACKGROUND: There has been an increasing interest in use of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure with preserved ejection fraction (HFPEF). However, a comprehensive evaluation of MRA effects on left ventricular (LV) structure and function in these patients is lacking. In this meta-analysis, we evaluated the effects of MRAs on LV structure and function among patients with diastolic dysfunction or HFPEF. METHODS & RESULTS: Randomized, controlled clinical trials evaluating the efficacy of MRAs in patients with diastolic dysfunction or HFPEF were included. The primary outcome was change in E/e', a specific measure of diastolic function. Secondary outcomes included changes in other measures of diastolic function, LV structure, surrogate markers for myocardial fibrosis (carboxy-terminal peptide of procollagen type I [PICP] and amino-terminal peptide of pro-collagen type-II [PIIINP]), blood pressure, and exercise tolerance. In the pooled analysis, MRA use was associated with significant reduction in E/e' (weighted mean difference [WMD] [95% confidence interval {CI}]: -1.68 [-2.03 to -1.33]; P CONCLUSION: MRA therapy in patients with asymptomatic diastolic dysfunction or HFPEF is associated with significant improvement in diastolic function and markers of cardiac fibrosis without a significant change in LV mass or dimensions. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => text )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => unknown )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://scholarlyworks.lvhn.org/medicine/5058; https://pubmed.ncbi.nlm.nih.gov/26459931/ )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://scholarlyworks.lvhn.org/medicine/5058<br />https://pubmed.ncbi.nlm.nih.gov/26459931/ )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.5372F5C2 )
RecordInfo Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => unknown ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Chi-Square Distribution [Type] => general ) [1] => Array ( [SubjectFull] => Diastole [Type] => general ) [2] => Array ( [SubjectFull] => Fibrosis [Type] => general ) [3] => Array ( [SubjectFull] => Heart Failure [Type] => general ) [4] => Array ( [SubjectFull] => Humans [Type] => general ) [5] => Array ( [SubjectFull] => Mineralocorticoid Receptor Antagonists [Type] => general ) [6] => Array ( [SubjectFull] => Randomized Controlled Trials as Topic [Type] => general ) [7] => Array ( [SubjectFull] => Recovery of Function [Type] => general ) [8] => Array ( [SubjectFull] => Stroke Volume [Type] => general ) [9] => Array ( [SubjectFull] => Treatment Outcome [Type] => general ) [10] => Array ( [SubjectFull] => Ventricular Dysfunction [Type] => general ) [11] => Array ( [SubjectFull] => Left [Type] => general ) [12] => Array ( [SubjectFull] => Ventricular Function [Type] => general ) [13] => Array ( [SubjectFull] => Ventricular Remodeling [Type] => general ) [14] => Array ( [SubjectFull] => Department of Medicine [Type] => general ) [15] => Array ( [SubjectFull] => Fellows and Residents [Type] => general ) [16] => Array ( [SubjectFull] => Medicine and Health Sciences [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review. [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pandey, Ambarish ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Garg, Sushil ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Matulevicius, Susan A ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Shah, Amil M ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Garg, Jalaj ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Drazner, Mark H ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Amin, Alpesh ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Berry, Jarett D ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Marwick, Thomas H ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Marso, Steven P ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => de Lemos, James A ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kumbhani, Dharam J ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2015 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Department of Medicine [Type] => main ) ) ) ) ) ) )
IllustrationInfo